The report on the global direct-to-consumer genetic testing market provides qualitative and quantitative analysis for the period from 2021-2030. The revenue generated by the market was USD 139.58 million in 2022 and is expected to reach 800.45 million in 2030 with a CAGR of 21.2% till 2030, during the projected period 2023-2030. The study on direct-to-consumer genetic testing market covers the analysis of the leading geographies such as North America, Europe, Asia Pacific, and RoW for the period of 2021-2030.
Direct-to-consumer (DTC) genetic testing is a type of genetic testing that is offered to consumers without a prescription or referral from a doctor. DTC genetic tests can be used to determine a person's genetic propensity for a number of ailments, such as diabetes, cancer, and heart disease. They can also be used to discover someone's family history. These tests are typically ordered online, and customers receive a testing kit at home, which usually involves providing a saliva or cheek swab sample. The sample is then sent back to the testing company, and the results are provided directly to the consumer through an online platform or app. The driving factor of the market is the increasing use of the internet consumers now have easier access to DTCGT services owing to the penetration of the Internet. Companies can now market their goods to customers directly via online channels such as websites and social media.
Carrier testing is expected to grab the highest share in the global market during the forecast period. Carrier testing basically focuses on identifying individuals carrying gene mutations that can be transmitted to their offspring, and this testing plays a crucial role in assessing the risk of passing on genetic disorders to future generations. It is particularly relevant for individuals with a family history of genetic conditions or those planning to start a family. The continued dominance of carrier testing can be attributed to its significant value in family planning and reproductive decision-making. By obtaining information about carrier status, individuals can make informed choices and take necessary precautions to reduce the likelihood of transmitting genetic disorders. Due to these several factors is expected to grab high shares in the global market.
North America is to grab the highest share in the global market. This can be attributed to the prevalent consumer attitudes towards genetic testing as the people here are more inclined towards health and aware of the diseases. Furthermore, the increase in expenditure further propels the growth of the demand for Direct-to-Consumer (DTC) genetic testing, which is expected to continue throughout the forecast period. The combination of consumer attitudes and increased expenditure contributes to the market's dominance in North America, establishing it as a leading region in the global DTC genetic testing market. Moreover, the market growth in the region is expected to be driven by the increasing number of product approvals and subsequent launches by the U.S. Food and Drug Administration (FDA). The FDA's role in approving and regulating genetic testing products will contribute to the expansion of the market. Additionally, the high concentration of key players in the region actively involved in research activities to innovate novel genetic testing products will further fuel market growth.
2. Internal and External subject matter experts
3. Professionals and participants from the industry
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
2. Complete coverage of all the segments in the direct-to-consumer genetic testing market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global direct-to-consumer genetic testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Direct-to-consumer (DTC) genetic testing is a type of genetic testing that is offered to consumers without a prescription or referral from a doctor. DTC genetic tests can be used to determine a person's genetic propensity for a number of ailments, such as diabetes, cancer, and heart disease. They can also be used to discover someone's family history. These tests are typically ordered online, and customers receive a testing kit at home, which usually involves providing a saliva or cheek swab sample. The sample is then sent back to the testing company, and the results are provided directly to the consumer through an online platform or app. The driving factor of the market is the increasing use of the internet consumers now have easier access to DTCGT services owing to the penetration of the Internet. Companies can now market their goods to customers directly via online channels such as websites and social media.
Carrier testing is expected to grab the highest share in the global market during the forecast period. Carrier testing basically focuses on identifying individuals carrying gene mutations that can be transmitted to their offspring, and this testing plays a crucial role in assessing the risk of passing on genetic disorders to future generations. It is particularly relevant for individuals with a family history of genetic conditions or those planning to start a family. The continued dominance of carrier testing can be attributed to its significant value in family planning and reproductive decision-making. By obtaining information about carrier status, individuals can make informed choices and take necessary precautions to reduce the likelihood of transmitting genetic disorders. Due to these several factors is expected to grab high shares in the global market.
North America is to grab the highest share in the global market. This can be attributed to the prevalent consumer attitudes towards genetic testing as the people here are more inclined towards health and aware of the diseases. Furthermore, the increase in expenditure further propels the growth of the demand for Direct-to-Consumer (DTC) genetic testing, which is expected to continue throughout the forecast period. The combination of consumer attitudes and increased expenditure contributes to the market's dominance in North America, establishing it as a leading region in the global DTC genetic testing market. Moreover, the market growth in the region is expected to be driven by the increasing number of product approvals and subsequent launches by the U.S. Food and Drug Administration (FDA). The FDA's role in approving and regulating genetic testing products will contribute to the expansion of the market. Additionally, the high concentration of key players in the region actively involved in research activities to innovate novel genetic testing products will further fuel market growth.
Report Findings
1) Drivers
- Affordability and personalization, decreasing costs of DTC genetic tests have made them more accessible to a wider population, driving the growth of the market.
- The appeal of having personalized insights and recommendations based on genetic information fuels the growth of the market.
2) Restraints
- Concerns surrounding the confidentiality of genetic data restrain the market.
3) Opportunities
- An opportunity for the market lies in rising pharmacogenetic research, as the field advances, DTC genetic testing companies can offer personalized insights into how genetic factors influence an individual's response to medications.
Research Methodology
A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents.The primary respondents are approached include
1. Key Opinion Leaders2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.The secondary sources of the data typically include
1. Company reports and publications2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
Segment Covered
The global direct-to-consumer genetic testing market is segmented on the basis of test type, technology type, and distribution channel.The Global Direct-to-Consumer Genetic Testing Market by Test Type
- Nutrigenomics Testing
- Predictive Testing
- Carrier Testing
- Skincare Testing
- Ancestry and Relationship Testing
The Global Direct-to-Consumer Genetic Testing Market by Technology Type
- Target Analysis
- Single Nucleotide Polymorphism (SNP) Chips
- Whole Genome Sequencing (WGS)
The Global Direct-to-Consumer Genetic Testing Market by Distribution Channel
- Online Platforms
- Over-the-Counter
Company Profiles
The companies covered in the report include- Full Genomes Corporation, Inc.
- EasyDNA
- Color Health, Inc.
- Gene by Gene, Ltd.
- Helix OpCo, LLC
- MyHeritage Ltd.
- 23andMe, Inc.
- Genesis HealthCare
- Ancestry
- Other Companies
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the direct-to-consumer genetic testing market.2. Complete coverage of all the segments in the direct-to-consumer genetic testing market to analyze the trends, developments in the global market and forecast of market size up to 2030.
3. Comprehensive analysis of the companies operating in the global direct-to-consumer genetic testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Global Direct-to-Consumer Genetic Testing Market Overview
Chapter 5. Company Profiles and Competitive Landscape
Chapter 6. Global Direct-to-Consumer Genetic Testing Market by Test Type
Chapter 7. Global Direct-to-Consumer Genetic Testing Market by Technology Type
Chapter 8. Global Direct-to-Consumer Genetic Testing Market by Distribution Channel
Chapter 9. Global Direct-to-Consumer Genetic Testing Market by Region 2023-2030
Companies Mentioned
- Full Genomes Corporation, Inc.
- EasyDNA
- Color Health, Inc.
- Gene by Gene, Ltd.
- Helix OpCo, LLC
- MyHeritage Ltd.
- 23andMe, Inc.
- Genesis HealthCare
- Ancestry
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 255 |
| Published | August 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value in 2022 | 139.58 Billion |
| Forecasted Market Value by 2030 | 800.45 Billion |
| Compound Annual Growth Rate | 21.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
